mTOR Inhibitor Immunosuppressant [EPC]

53327 reported adverse events

Drugs of this class: SIROLIMUS EVEROLIMUS EVEROLIMUS TABLETS

These side effects are most commonly reported by patients taking drugs of the mTOR Inhibitor Immunosuppressant [EPC] class:

# Side effect Count
0 DEATH 5904
1 DIARRHOEA 3915
2 MALIGNANT NEOPLASM PROGRESSION 3842
3 FATIGUE 3450
4 STOMATITIS 2925
5 NAUSEA 2613
6 DYSPNOEA 2610
7 PYREXIA 2520
8 OFF LABEL USE 2299
9 DRUG INEFFECTIVE 2174
See all common reactions for mTOR Inhibitor Immunosuppressant [EPC]

Drugs of the mTOR Inhibitor Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 72 0.4500
1 TRANSPLANT DYSFUNCTION 486 0.3879
2 PIK3CA-ACTIVATED MUTATION 56 0.3836
3 POLYOMAVIRUS VIRAEMIA 94 0.2994
4 FOCAL GLOMERULOSCLEROSIS 29 0.2736
5 PANCREATIC NEUROENDOCRINE TUMOUR 98 0.2456
6 NEUROENDOCRINE TUMOUR 190 0.2023
7 SMOOTH MUSCLE CELL NEOPLASM 34 0.1932
8 LYMPHOCELE 112 0.1911
9 HUMAN POLYOMAVIRUS INFECTION 58 0.1763
See all enriched reactions for mTOR Inhibitor Immunosuppressant [EPC]